Predicting the number of oocytes retrieved from controlled ovarian hyperstimulation with machine learning.
Timothy Ferrand, Justine Boulant, Chloe He...
https://pubmed.ncbi.nlm.nih.gov/37581894/Actively Recruiting
Led by Fundacion Dexeus · Updated on 2026-04-22
644
Participants Needed
5
Research Sites
21 weeks
Total Duration
Researchers are investigating whether using artificial intelligence AI to guide monitoring and timing of ovulation trigger in women undergoing ovarian stimulation for in vitro fertilization IVF can achieve clinical outcomes similar to traditional physician-led decisions. This trial aims to compare AI-assisted decision-making with routine clinical management to optimize the number of eggs retrieved, improve workflow efficiency, and reduce clinical workload, especially weekend procedures. Participants will be randomly assigned to one of two groups one where trigger decisions are made by the physician assisted by the AI software called STIMAI, and the other where trigger timing is determined by the physician alone based on clinical judgement. The AI software analyzes patient data to predict the optimal trigger day, offering options for triggering today or tomorrow, while the physician makes the final decision. The study focuses on individualized treatment to improve outcomes and scheduling. During the study, participants will undergo controlled ovarian stimulation with regular monitoring including ultrasounds. Researchers will measure the number of mature eggs retrieved about 34-36 hours after ovulation trigger, as well as other outcomes like follicle counts, length of stimulation, and number of clinic visits. The trial also tracks spontaneous ovulation and the distribution of retrieval procedures throughout the week. Participation will last through the stimulation cycle until egg retrieval, with assessments of both clinical results and process efficiency.
CONDITIONS
AI-TOP Study Artificial Intelligence for Trigger Optimization.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fundacion Dexeus
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 8 to 15 days
Participants undergo controlled ovarian stimulation with trigger timing decided either by the physician assisted by AI guidance or by the physician alone following routine clinical management.
Up to 8 to 12 visits for monitoring and stimulation
Duration - Approximately 1 day
Participants attend follow-up visits for oocyte retrieval approximately 34 to 36 hours after ovulation trigger and assessment of clinical outcomes.
1 visit (in-person) for oocyte retrieval and assessment
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Timothy Ferrand, Justine Boulant, Chloe He...
https://pubmed.ncbi.nlm.nih.gov/37581894/Elnur Babayev
https://pubmed.ncbi.nlm.nih.gov/32819677/Gerard Letterie, Andrew MacDonald, Zhan Shi
https://pubmed.ncbi.nlm.nih.gov/34865998/Chelsea Canon, Lily Leibner, Michael Fanton...
https://pubmed.ncbi.nlm.nih.gov/39164339/Eduardo Hariton, Ethan A Chi, Gordon Chi...
https://pubmed.ncbi.nlm.nih.gov/34256948/Christophe Blockeel, Sara Engels, Michel De Vos...
https://pubmed.ncbi.nlm.nih.gov/22296973/Darren J X Chow, Philip Wijesinghe, Kishan Dholakia...
https://pubmed.ncbi.nlm.nih.gov/35118395/Irene Dimitriadis, Nikica Zaninovic, Alejandro Chavez Badiola...
https://pubmed.ncbi.nlm.nih.gov/35027326/Fundacion Dexeus
Lead Sponsor